Gil M Labrucherie
NKTRGil M Labrucherie serves as Chief Financial Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Gil M Labrucherie's Insider Trading at Nektar Therapeutics (NKTR)
Buys
0 · $0.00
Sells
5 · $762.3K
Total Shares Bought
0
Total Shares Sold
67,941
Gil M Labrucherie's Insider Trading at Septerna, Inc. (SEPN)
Buys
2 · $229.2K
Sells
0 · $0.00
Total Shares Bought
40,000
Total Shares Sold
0
Gil M Labrucherie's Insider Trading at Rezolute, Inc. (RZLT)
Buys
1 · $200.0K
Sells
0 · $0.00
Total Shares Bought
52,631
Total Shares Sold
0
Related Insiders
Elizabeth Bhatt
President and COO
SEPNSell · Apr 17, 2026
Jonathan Zalevsky
officer: Chief R&D Officer
NKTRSell · Feb 18, 2026
ROBIN HOWARD W
President & CEO
NKTRSell · Feb 18, 2026
Wladimir Hogenhuis
Director
RZLTBuy · Dec 16, 2025
ROBERTS BRIAN KENNETH
Chief Medical Officer
RZLTBuy · Dec 16, 2025
Daron Evans
CFO
RZLTBuy · Dec 15, 2025
Sunil Ratilal Karnawat
Chief Commercial Officer
RZLTBuy · Dec 15, 2025
Nevan C Elam
CEO
RZLTBuy · Dec 15, 2025